There is no definite free-for-all HIV-AIDS cure for the general population, but there is a potential cure for those infected with the virus. While there has been only 3 publicly reported cases where the HIV-AIDS disease has completely vanished from the patients’ blood streams, un-reported cases may be significantly more, as many people keep their HIV statuses private and don’t disclose them due to the fact of stigmatization.
Of the three publicly disclosed cases of HIV-AIDS being cured, two were of babies that were born with HIV but soon after, they were put on antiretroviral therapy (ART). After being test again after a couple of years, the virus has completely vanished from their blood stream. One of the two patients had stopped taking ART completely and had still tested negative after 4 years.
Of the three cases, the most unique and publicly known is of a British man, Timothy Ray Brown, he remains the only individual to have been completely rid of the virus, but scientists were not sure which aspect of his treatment was responsible for curing him.
Timothy Brown was diagnosed with HIV in 1995. He had been taking anti-HIV drugs, or antiretroviral therapy (ART), for 11 years to control his infection before learning that he had developed leukemia. He was given chemotherapy but it failed, so physicians decided to proceed with a bone marrow transplant in 2007. The treatment successfully cured his cancer, but interestingly the virus dropped to undetectable levels in his blood and never bounced back, despite Brown ditching ART.
Brown was given a transplant from an individual with rare a mutation that alters one of the receptors HIV uses to get inside white blood cells, making him resistant to HIV-AIDS.
While the general population who are infected with HIV-AIDS all can’t receive bone marrow transplants from HIV-AIDS immune donors and if there was already a generic cure created, it won’t be available in the next couple of 100 years, as the HIV-AIDS drug business makes over 400 billion in profits.
Remember: the medicine world is not in the business of curing diseases, but maintaining them by only allievating the symptoms.
There still is a largely un-researched treatment option that is making waves in the non-corporate medical faternity and it is using silver nano-particles (that can be made in one’s own home) for the treatment of HIV-AIDS.
The Famous HIV Study using Silver Nano-particles
In June 2005, the prestigious journal Nanobiotechnology published a ten page study that rocked medical science.
The study was the result of seven scientists’ exploration into the virus inhibiting qualities of nanosilver – very tiny, invisible particles of silver measured in nanometers. (A nanometer is one-billionth of a meter, or one-ten thousandth of a hair’s breadth.)
What the study demonstrated is that these tiny nano-scale particles of silver were able to inhibit HIV-1 from binding to host cells, in vitro.
What this means is that in the test tube, when the researchers placed the AIDS virus alongside human cells in a medium that would normally allow the virus to bind with the cell (and thus cause viral infection), the introduction of tiny nano-particles of silver into the medium prevented the binding from taking place.
In other words, the silver particles stopped the infection from taking place.
The study abstract reads as follows:
The interaction of nanoparticles with biomolecules and microorganisms is an expanding field of research. Within this field, an area that has been largely unexplored is the interaction of metal nanoparticles with viruses.”
In this work, we demonstrate that silver nanoparticles undergo a size-dependent interaction with HIV-1, with nanoparticles exclusively in the range of 1-10 nm attached to the virus.”
The regular spatial arrangement of the attached nanoparticles, the center-to-center distance between nanoparticles, and the fact that the exposed sulfur-bearing residues of the glycoprotein knobs would be attractive sites for nanoparticle interaction suggest that silver nanoparticles interact with the HIV-1 virus via preferential binding to the gp120 glycoprotein knobs.”
Due to this interaction, silver nanoparticles inhibit the virus from binding to host cells, as demonstrated in vitro.”
While silver’s well-known toxicity to a wide range of bacterial and fungal pathogens has been thoroughly documented in previous research by many leading research facilities, this study takes the previous research to a whole new level.
For the first time, the long-proven antimicrobial properties of silver nanoparticles were applied to a highly infectious form of virus with no known cure. And the interaction between the metallic particles, the virus and the cells were studied.
The scientists tested a variety of particle sizes. And they also tested the idea of coating the tiny silver particles with several different surface chemistries including a “foamy carbon matrix,” a polymer and a protein molecule. The goal was to determine if any of these substances would help stabilize the silver particles and aid the silver’s anticipated reaction with the virus.
What they discovered, however, is that only the ‘free surface’ silver nano-particles in the range of 1 to 10 nanometers interacted with the HIV-1 cells. This basically means the silver needed no help from the other substances. In fact, anything added to the basic silver nanoparticle served only to prevent the metal’s interaction with the viral micro-organism.
What’s more, according to the study, only the very smallest silver particles inhibited the virus’ ability to bond with the host cells, larger particles did not.
Ultimately the study found that the tiny silver nano-particles no larger than 10 nm were able to bond to the deadly viral micro-organisms and prevented the virus from bonding with the host cell. No bonding to host cell, no viral infection.
The 2010 Study by the Prestigious Journal Nanobiotechnology
On the 20th January 2010, Nanobiotechnology published another study, in which it was demonstrated that “HIV infectivity is effectively eliminated following short exposure of isolated virus to silver nanoparticles.”
In other words, the study demonstrates that silver nanoparticles can be used to stop the AIDS virus from infecting human cells.
What’s more, according to the study, silver nanoparticles inhibit HIV infection at concentrations that do not cause harm to human cells. And according to the study conclusions, drug-resistant strains of HIV are apparently just as vulnerable to the silver nanoparticles as non-drug resistant strains.
This new study has allowed researchers to gain several additional important insights into the mechanism underlying the HIV-inhibitory activity of silver nanoparticles. It is almost inevitable that this new information will serve as a basis for further research into using silver nanoparticles to stop AIDS infections.
Here are some pertinent excerpts from this remarkable new study:
Silver nanoparticles proved to be an antiviral agent against HIV-1, but its mode of action was not fully elucidated.”
Is gp120 its principal target? Do silver nanoparticles act as entry inhibitors?”
In this study, we investigated the mode of antiviral action of silver nanoparticles against HIV-1. Our results reveal, for the first time, that silver nanoparticles exert anti-HIV activity at an early stage of viral replication, most likely as a virucidal agent or viral entry inhibitor.”
No significant difference was found in the antiviral activities of silver nanoparticles against the different drug-resistant strains (Table 1), so the mutations in antiretroviral HIV strains that confer resistance do not affect the efficacy of silver nanoparticles.”
These results further agree with previous findings, where it was proven that silver nanoparticles are broad-spectrum biocides [30,31]”
HIV-1 strains found in the human population can differ widely in their pathogenicity, virulence, and sensitivity to particular antiretroviral drugs ”
The fact that silver nanoparticles inhibit such a varied panel of strains makes them an effective broad-spectrum agent against HIV-1. This particular property can reduce the likelihood of the emergence of resistance and the subsequent spread of infection.”
… Silver nanoparticles proved to be virucidal to cell-free and cell-associated HIV-1 as judged by viral infectivity assays (Figures (Figures33 and and4).4).”
HIV infectivity is effectively eliminated following short exposure of isolated virus to silver nanoparticles. Silver nanoparticle treatment of chronically infected H9+ cells as well as human PBMC+ resulted in decreased infectivity.”
… Silver nanoparticles act directly on the virus at steps that prevent integration inside the host cell, but further pharmacokinetic, pharmacodynamic, and toxicological studies in animal models are needed to define safety parameters for the use of silver nanoparticles as preventive tools for HIV-1 transmission.”
…Finally, we propose that the antiviral activity of silver nanoparticles results from their inhibition of the interaction between gp120 and the target cell membrane receptors. According to our results, this mode of antiviral action allows silver nanoparticles to inhibit HIV-1 infection regardless of viral tropism or resistance profile, to bind to gp120 in a manner that prevents CD4-dependent virion binding, fusion, and infectivity, and to block HIV-1 cell-free and cell-associated infection, acting as a virucidal agent.”
In conclusion, silver nanoparticles are effective virucides as they inactivate HIV particles in a short period of time, exerting their activity at an early stage of viral replication (entry or fusion) and at post-entry stages. The data presented here contribute to a new and still largely unexplored area; the use of nanomaterials against specific targets of viral particles.”
How astonishing is it that the corporate medicine world has not even conducted published studies into this miracle Silver nano-particles and why has various studies conducted in 1991, 1993 and 1995 on silver nanoparticles by U.S government agencies never been published or disclosed.
Why do those studies remain classified and why does the U.S government hold a patent for the HIV-AIDS cure?
Comment below and let us know what you think.